Press enter to main content:::
Timeline COVID-19
- 701Fifth round of free rapid test distribution program for elderly people aged 65 and older, seventh round of free rapid test distribution program for children six and under to begin on Jan. 10 through Feb. 28; free rapid test kits to be given to disadvantaged individuals and people with physical or mental disabilities from Jan. 12 to Feb. 15
- 702CECC announces information on contracted healthcare facilities providing in-person, video consultations for COVID-19 and oral antiviral drugs during Lunar New Year holiday to provide information to public
- 703CECC launches Lunar New Year Healthcare Program to safeguard COVID-19 prevention and healthcare capacities
- 704To continue detecting high-risk variants from China and implementing special travel arrangement for Kinmen and Matsu residents, saliva-based PCR testing for travelers arriving on direct flights from China and through special travel program extended to Feb. 6
- 705Regular rapid testing measures at residential and community care institutions extended until Feb 28, 2023
- 70610th round of name-based rationing system for at-home COVID-19 rapid test kits to begin on Feb. 1, and people can purchase rapid tests with their NHI cards; children six and under and elderly people 65 and older who are eligible for free rapid tests and haven't collected rapid tests can still get them with their NHI cards before Feb. 28
- 707CECC reminds people who haven't completed their primary series vaccination to get vaccinated as soon as possible and to pay attention to availability of Pfizer/BioNTech COVID-19 vaccine appointments
- 708Starting Feb. 7, Taiwan to ease entry and quarantine requirements, lift saliva PCR testing on arrivals from China at airports/ports; arrivals still need to undergo 7-day period of self-initiated prevention and only need to take rapid tests if they have symptoms
- 709With steady easing of COVID-19 measures, Taiwan to adjust test time rule for arrivals during their 7-day period of self-initiated prevention from Feb. 7
- 710CECC visits 22 counties and cities to discuss strategies for increasing COVID-19 vaccination rates and obtain feedback from local governments on COVID-19 response
- 711To start regular surveillance of seropositivity of SARS-CoV-2 antibodies, Taiwan Blood Services Foundation to implement SARS-CoV-2 antibody surveillance system
- 712CECC announces plans to relax indoor mask rules; eased rules scheduled to take effect on Feb. 20 if pandemic situation remains stable
- 713Regular rapid testing measures at community care institutions discontinued effective on Feb 27, 2023; the frequency of rapid testing for care recipients in residential care institutions relaxed to once a week and will remain till March 31
- 71411th round of name-based rationing system for at-home COVID-19 rapid test kits to begin on March 1, and people can purchase rapid tests with their NHI cards; children six and under and elderly people 65 and older who are eligible for free rapid tests should collect rapid tests with their NHI card as soon as possible, and these two distributing programs will end on Feb. 28 this year as scheduled
- 715Starting March 1, arrivals and close contacts of confirmed cases no longer receive free COVID-19 at-home rapid tests
- 7162023 National COVID-19 Vaccination Campaign" with its main theme being "Vaccine Plus One. Easing Restriction Safely" will be launched on March 6
- 717Pfizer/BioNTech COVID-19 vaccine available again for individuals under 18 as their first dose; those who have not completed their primary series vaccination can receive this vaccine
- 718Taiwan Social Distancing app to give push notifications about clarification of epidemic prevention information and disinformation
- 719COVID-19 recommendations on infection control for handling of bodies of deceased COVID-19 patients adjusted on March 20 in response to loosened epidemic prevention and control rules
- 720Effective March 20, mild COVID-19 cases exempt from reporting, isolation and should seek medical care immediately if they experience severe symptoms/warning signs; high-risk individuals meeting criteria can still receive oral antiviral medications
